11 Manufacture, marketing, supply and field trials
Medicines and Medical Devices Act 2021 (2021 c 3) | Legislation

11  Manufacture, marketing, supply and field trials

(1)     Regulations under section 10(1) may make provision about—

(a)     authorisations to manufacture veterinary medicines,

(b)     authorisations to import veterinary medicines,

(c)     authorisations to distribute veterinary medicines by way of wholesale dealing,

(d)     marketing authorisations,

(e)     marketing, importing or distributing active substances,

(f)     the categories of person who may supply veterinary medicines,

(g)

Powered by Lexis+®
 

Popular documents

LEXISNEXIS

Proprietary estoppel

Proprietary estoppelThis Practice Note considers proprietary estoppel from a generic standpoint.For industry specific guidance on proprietary estoppel, see Practice Notes:•Estoppel and property law•Mortgages by estoppelProprietary estoppel—what is it?Unlike the other forms of estoppel (see Practice

LEXISNEXIS

Subrogation in insurance and reinsurance

Subrogation in insurance and reinsuranceWhat is the right of subrogation?In the context of insurance and reinsurance, the right of subrogation entitles an insurer or reinsurer, having indemnified the (re)insured, to ‘step into its shoes’ to bring an action in the (re)insured’s name. For the purpose

LEXISNEXIS

VAT definition

LEXISNEXIS

Common financial covenants

Common financial covenantsThis Practice Note explains certain common financial covenants used in commercial finance transactions including:•minimum net worth test•gearing ratio•leverage ratio (or debt to equity ratio)•current ratio (or acid test ratio)•cashflow ratio•interest cover ratio, and•loan